Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS: In this multicenter, randomized, double-blind study, 280 patients with mildly to moderately active ulcerative colitis (UC) recei...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intest Res
Autors principals: Ogata, Haruhiko, Aoyama, Nobuo, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Format: Artigo
Idioma:Inglês
Publicat: Korean Association for the Study of Intestinal Diseases 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478762/
https://ncbi.nlm.nih.gov/pubmed/28670234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2017.15.3.368
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars